AMP kinase acts as a negative regulator of RANKL in the differentiation of osteoclasts
- 30 November 2010
- journal article
- Published by Elsevier BV in Bone
- Vol. 47 (5), 926-937
- https://doi.org/10.1016/j.bone.2010.08.001
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Epigallocatechin-3-gallate Inhibits Osteoclastogenesis by Down-Regulating c-Fos Expression and Suppressing the Nuclear Factor-κB SignalMolecular Pharmacology, 2009
- Germline deletion of AMP‐activated protein kinase β subunits reduces bone mass without altering osteoclast differentiation or functionThe FASEB Journal, 2009
- TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cellsThe EMBO Journal, 2009
- AMP-activated Protein Kinase Activation Increases Phosphorylation of Glycogen Synthase Kinase 3β and Thereby Reduces cAMP-responsive Element Transcriptional Activity and Phosphoenolpyruvate Carboxykinase C Gene Expression in the Liver*Published by Elsevier BV ,2008
- SIRT1 Regulates Hepatocyte Lipid Metabolism through Activating AMP-activated Protein KinasePublished by Elsevier BV ,2008
- Berberine improves glucose metabolism through induction of glycolysisAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Epigallocatechin-3-gallate (EGCG), A Green Tea Polyphenol, Suppresses Hepatic Gluconeogenesis through 5′-AMP-activated Protein KinasePublished by Elsevier BV ,2007
- Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascadeBiochemical Journal, 2007
- Thrombin Activates AMP-Activated Protein Kinase in Endothelial Cells via a Pathway Involving Ca2+/Calmodulin-Dependent Protein Kinase Kinase βMolecular and Cellular Biology, 2006
- Osteoclast differentiation and activationNature, 2003